An increased number of companies are noticing presenteeism and assessing functional capacity alongside attendance. The real losses begin when people are present but not fully able to perform due to mental health issues. That drop in capacity reduces output, quality, and speed long before it appears in attendance reports, creating a silent profit drain across teams and regions that most dashboards do not detect.
This article presents a practical, enterprise‑ready way to make that hidden risk visible and manageable, grounded in ifeel’s internal clinical research. By measuring functional capacity with validated tools and acting early through scalable digital support, organisations can reduce work impairment, cut absences, stabilise retention, and demonstrate clear ROI.
For the complete methodology and results, download ifeel’s 2025 whitepaper “The Silent Profit Drain”, and learn more about ifeel’s mental health solution.
Beyond attendance
Attendance shows who is present. It does not show how well people perform. In enterprise organisations, many employees experience reduced work capacity, particularly when symptoms persist. In our multi‑country research, over half of assessed employees fell into higher impairment ranges, and 51% scored above 4 on an 8‑point scale, which indicates elevated absence risk.
This is why functional capacity matters. Without measuring it, organisations miss where performance is declining and why.
Presenteeism amplifies the issue. Employees may be online and in meetings, yet performing below their usual level. Over time, that gap extends deadlines and reduces quality across teams. Measuring functional capacity helps you identify and address this early. Unplanned absences also carry direct costs, reaching up to 8% of annual payroll in global organisations.
ROI calculation example:
For a 1,000-employee company with €50,000 average salary:
- Potential absenteeism cost: €4 million annually (8% of payroll)
- High-risk employees identified: 510 (51% of workforce)
- Early intervention cost avoidance: €2+ million annually
Conclusion: ifeel’s predictive assessment capabilities enable enterprise organisations to identify over half of their workforce at risk for costly absenteeism, providing clear pathways for intervention that can save millions in direct payroll costs while maintaining productivity levels.
Absenteeism vs presenteeism: two sides of the same cost
- Absenteeism is visible and budgeted. In many organisations it appears directly in sick‑leave and time‑off records.
- Presenteeism is largely invisible. Employees are present but working below capacity, which quietly reduces output and quality and rarely appears in standard reports.
- Why it matters to HR and leaders: Absence data shows part of the picture. Functional capacity reveals the rest. Tracking both gives a more accurate view of where performance is slipping and where support will deliver the greatest return.
Why reactive models fall short
Traditional solutions focused on last-mile support often reach only a small fraction of the workforce. By contrast, private, easy-to-access, and localised digital mental health solutions consistently engage a much larger share of employees and enable earlier intervention. That shift from limited, reactive use to broad, proactive engagement is what turns well-being from a benefit into a performance lever.
A predictive prevention model HR can run
ifeel combines validated assessment with data-driven care to identify risk early and route employees to the right support:
- WSAS-1 identifies early work and social adjustment issues associated with a higher risk of absenteeism.
- SOFAS measures functional capacity over time, showing whether people are recovering in ways that improve day-to-day performance.
In our data, the warning signs appear early and often persist for a long time. Many employees report symptoms above a moderate level, and a large proportion have been experiencing them for over a year. Depression has the biggest impact on people’s ability to work: moderate depression is linked to almost double the level of work impairment compared with minimal symptoms, and severe depression roughly doubles it. Focusing support on depression and moderate to severe anxiety, with clinician‑led programmes, delivers the most significant improvement in functional capacity.
Clinical research and tools
ifeel’s approach is grounded in evidence-based instruments and longitudinal designs that track both clinical and functional outcomes. Over the last year, our research included adults aged 18 to 64 across general and employee populations, using pre-post designs with multiple measurement points. We employ validated tools to ensure rigor and comparability:
- SOFAS (Social and Occupational Functioning Assessment Scale): Measures psychosocial and occupational functioning, enabling risk stratification and performance-relevant tracking over time.
- WSAS-1 (Work and Social Adjustment Scale): Identifies early functional interference that predicts absenteeism risk and informs routing to care.
- GAD-7 (Generalised Anxiety Disorder-7): Screens and monitors anxiety severity to tailor interventions and measure improvement.
- PHQ-9 (Patient Health Questionnaire-9): Screens and monitors depressive symptom severity, critical for targeting the highest impairment drivers.
- Customer Satisfaction Questionnaire: Captures user experience to augment clinical and functional metrics.
Across studies, statistical analyses show sustained reductions in anxiety and depression alongside consistent gains in psychosocial functioning. Improvements in these clinical variables are associated with reduced absenteeism risk, reinforcing the organisational impact of early, sustained care.
Impact you can measure
Before investing, leaders want clarity on the concrete outcomes they can expect. Here are the enterprise‑level benefits most commonly achieved when a mental health solution is deployed at scale.
- Higher engagement across the workforce
Digital programmes reliably achieve 30-50% participation, enabling prevention beyond traditional single-digit utilisation. - Measurable ROI
By reducing work impairment, cutting absences, and improving retention, organisations see clearer savings and more substantial long‑term returns.. - Recovery of hidden productivity
Tackling functional impairment and presenteeism restores performance that attendance data alone will never reveal. - Focus where the impact is highest
Depression and moderate to severe anxiety drive the largest impairment, so prioritising these pathways recovers the most capacity. - Predictive visibility
Validated tools and population-level dashboards provide early signals by unit and region, allowing teams to act before losses peak.
Workplace mental health: a global business challenge
Presenteeism and reduced functional capacity are measurable, manageable risks. When organisations look beyond attendance and use validated tools such as WSAS‑1 and SOFAS, they can detect issues earlier, direct support where it is most needed, and protect performance at scale.
With up to 8% of payroll exposed to unplanned absence and more than half of assessed employees showing higher impairment risk, the case for early, evidence‑based intervention is clear. Strong engagement in therapy, particularly among higher‑risk groups, further supports retention and recovery. Taken together, these elements form a practical, defensible approach to improving both well-being and business outcomes.
ifeel partners with global organisations to operationalise this approach through evidence‑based assessments, clinician‑led programmes, and secure, privacy‑first technology. If you’d like to explore how this can work in your context, download ifeel’s 2025 whitepaper “The Silent Profit Drain” and start your solution with our team.
About the author:
Surya is an international marketing specialist and content creator, working in partnership with ifeel’s clinical research team. She identifies evolving needs across global markets and delivers an integrated approach that blends strategic marketing with deep expertise in mental wellbeing to produce innovative, educational content. She writes extensively about the financial impact of mental health in enterprise organisations, translating complex wellbeing challenges into clear, actionable narratives for decision-makers. Her work is grounded in rigorous research and preventive, evidence-based practice, strengthening engagement, mitigating absenteeism, and turning wellbeing gains into measurable productivity improvements and tangible cost efficiencies.
You might also like:
